Table 3.

Multivariate analysis of baseline and serial CA features after relapse (using indicators of CA status at baseline, between baseline and first transplant, and between first transplant and relapse) associated with post-relapse survival

Variable	N/N (%)	HR (95% CI)	P-value
CA at baseline	159/366 (43)	1.35 (1.01, 1.81)	0.044
CA between  baseline and  first transplant	73/366 (20)	1.08 (0.77, 1.52)	0.665
CA at relapse	107/366 (29)	2.47 (1.84, 3.33)	<0.001
TT protocols	245/366 (67)	0.66 (0.50, 0.87)	0.003
Creatinine≥2.0 mg  per 100 ml	10/366 (3)	2.42 (1.26, 4.66)	0.008

Abbreviations: CA, cytogenetic abnormalities; CI, confidence interval; HR, hazard ratio; TT, total therapy.